Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$12.56 - $18.31 $648,096 - $944,795
51,600 New
51,600 $827,000
Q1 2022

May 13, 2022

SELL
$6.96 - $12.15 $251,798 - $439,562
-36,178 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$11.72 - $19.66 $189,336 - $317,607
16,155 Added 80.68%
36,178 $433,000
Q3 2021

Nov 10, 2021

SELL
$16.73 - $20.9 $120,790 - $150,898
-7,220 Reduced 26.5%
20,023 $355,000
Q2 2021

Aug 10, 2021

SELL
$17.23 - $22.02 $35,373 - $45,207
-2,053 Reduced 7.01%
27,243 $559,000
Q1 2021

May 10, 2021

BUY
$18.38 - $28.41 $538,460 - $832,299
29,296 New
29,296 $581,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $217M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.